ClinicalTrials.Veeva

Menu

Performance of Pulmonary Embolism Risk Scores Out Come in CTPA Confirmed Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Pulmonary Embolism

Study type

Observational

Funder types

Other

Identifiers

NCT05613855
performance score outcome

Details and patient eligibility

About

  1. Assess performance of PERFORM score in predicting outcome in CTPA confirmed patients.
  2. Compare PERFORM score with the currently validated PESI in risk stratification of patients

Full description

Pulmonary embolism (PE) is a common and potentially lethal condition in the emergency department requiring early and accurate management.

The short-term mortality rate of PE varies widely and ranges from less than 2% in many patients with non massive PE to more than 95% in patients who experience cardiorespiratory arrest.

Although several prognostic models of acute PE are currently used, all of them have practical limitations.

Of all clinical scores integrating PE severity and comorbidity, the Pulmonary Embolism Severity Index (PESI) and its simplified version,(sPESI) have been most extensively validated to date.

However, current prognostic scores for pulmonary embolism (PE) are partly based on patients without PE confirmation via computed tomographic pulmonary angiography (CTPA), involving subjective parameters and complicated scoring methods [8].

Therefore, an objective, accurate, and simple prognostic model in CTPA-confirmed patients to predict the risk of 30-day mortality. help clinicians assess patients' risks and improve therapeutic decision-making that is called PERFORM score (pulmonary embolism risk score for mortality)

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients above 18 years old with PE confirmed by CTPA are considered for inclusion in the study.

Exclusion criteria

  • • Patients who have contraindications for CTPA eg. Renal impairment

    • Patients diagnosed and treated as PE without doing CTPA.
    • Patients who refuse to participate in the study

Trial contacts and locations

0

Loading...

Central trial contact

Suzan Salama Sayed, professor; Nourhan Safwat Abdelraheem, resiedent doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems